Stock Analysis
- India
- /
- Commercial Services
- /
- NSEI:BANKA
Banka BioLoo Third Quarter 2024 Earnings: EPS: ₹0.65 (vs ₹1.00 in 3Q 2023)
Banka BioLoo (NSE:BANKA) Third Quarter 2024 Results
Key Financial Results
- Revenue: ₹140.7m (up 31% from 3Q 2023).
- Net income: ₹7.01m (down 35% from 3Q 2023).
- Profit margin: 5.0% (down from 10% in 3Q 2023). The decrease in margin was driven by higher expenses.
- EPS: ₹0.65 (down from ₹1.00 in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Banka BioLoo shares are down 9.5% from a week ago.
Risk Analysis
Be aware that Banka BioLoo is showing 4 warning signs in our investment analysis and 3 of those are potentially serious...
Valuation is complex, but we're helping make it simple.
Find out whether Banka BioLoo is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:BANKA
Banka BioLoo
Banka BioLoo Limited engages in the sanitation, fecal sludge, and wastewater treatment businesses in India.
Imperfect balance sheet and overvalued.